ABBOTT LABORATORIES acquires Guidant's vascular intervention and endovascular businesses
Snapshot
ABBOTT LABORATORIES acquired Guidant's vascular intervention and endovascular businesses for approximately $4.1 billion (acquired from Boston Scientific in connection with its acquisition of Guidant) in April 2006. The transaction was structured as combination (cash plus a loan and milestone payments). Guidant's vascular intervention and endovascular businesses is a Santa Clara, California, USA-based Medical devices — vascular intervention business.
- Acquirer
- ABBOTT LABORATORIES
- Target
- Guidant's vascular intervention and endovascular businesses
- Value
- approximately $4.1 billion (acquired from Boston Scientific in connection with its acquisition of Guidant)
- Date
- April 2006
- Type
- carve-out
- Status
- ready
The deal at a glance
About this deal
ABBOTT LABORATORIES acquired Guidant's vascular intervention and endovascular businesses for approximately $4.1 billion (acquired from Boston Scientific in connection with its acquisition of Guidant), a transaction completed in April 2006, structured as combination (cash plus a loan and milestone payments). The deal was a carve-out.
Guidant's vascular intervention and endovascular businesses operates in Medical devices — vascular intervention, is based in Santa Clara, California, USA. Guidant's vascular intervention and endovascular solutions businesses, including coronary and peripheral stent and angioplasty product lines, acquired from Boston Scientific as a condition of Boston Scientific's acquisition of Guidant.
Combination of Abbott's and Guidant's vascular organizations creates a stronger vascular business and gives Abbott a leading position in vascular intervention.
Established Abbott as a major player in the global vascular intervention market with a drug-eluting stent pipeline. Became Abbott Vascular
No advisory firms have been disclosed for this transaction.